Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Kinross Gold Corporation (KGC) vs Tenet Healthcare Corporation (THC) Price & Performance

Kinross Gold CorporationTrade
Tenet Healthcare CorporationTrade

Price performance (Past 24H)

Key statistics

Kinross Gold Corporation vs Tenet Healthcare Corporation — how do they compare? Kinross Gold Corporation trades at $23.74 (market cap $27.62B), while Tenet Healthcare Corporation trades at $263.78 (market cap $20.98B). The key difference: Kinross Gold Corporation is the larger of the two by market cap, and Kinross Gold Corporation pays a 0.69% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals — on Pluang, investors hold Kinross Gold Corporation for 53 Days and Tenet Healthcare Corporation for 15 Days on average.

KGCTHC
Market Cap
$27.62B$20.98B
Volume
6,347,266428,008
Sector
Basic MaterialsHealth
52-Week High
$38.06$280.77
52-Week Low
$22.47$161.37
Typical Hold Time
53 Days15 Days
Enterprise Value
$25.70B$32.06B
Dividend Yield
0.69%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Kinross Gold Corporation

Kinross Gold Corporation (KGC) trades at $23.34, up 0.69% today, with strong fundamentals including a P/E of 8.87 and robust profitability metrics. Recent earnings have consistently beaten expectations, though technical indicators signal bearish momentum. The company reported $7.05B revenue and $2.39B net income for 2025, with cash flow from operations reaching $3.76B. However, production guidance cuts for 2026-2027 have pressured the stock, offset by increased shareholder returns targeting 50% of free cash flow.

KGC presents a mixed outlook: attractive valuation and earnings growth support upside to the $38.80 consensus price target, but near-term risks include operational setbacks at key mines and ongoing legal investigations. The stock's bearish technical trend and rising costs warrant caution, though institutional buying and high analyst buy ratings (58.63%) indicate underlying confidence in long-term value.

Tenet Healthcare Corporation

Tenet Healthcare (THC) trades at $263.78, up 1.52% today, with a bullish technical signal from moving averages and strong fundamental support. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 29, 2026. Revenue grew to $21.31B in 2025, with a robust net income margin of 9.9% and high return on equity of 53.31%, while valuation ratios like P/E of 10.07 and EV/EBITDA of 5.75 suggest potential undervaluation.

The outlook is positive, driven by earnings momentum and analyst consensus favoring buys, with a price target of $283.36 offering upside. Risks include reliance on surgical volumes and capital return sustainability, but strong cash flow and efficiency gains support growth. Investors should weigh solid fundamentals against sector-specific headwinds.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

KGC
1% Buy99% Sell
Avg holding period · 53 Days
THC

No sentiment data available yet.

Top news

Latest headlines on both assets

About Kinross Gold Corporation

Kinross Gold is a Canada-based senior gold producer, producing roughly 2.4 million gold equivalent ounces in 2020. The company had 30 million ounces of proven and probable gold reserves and 59 million ounces of silver reserves at the end of 2020. It operates mines and focuses its greenfield and brownfield exploration in the Americas, West Africa, and Russia. The company has historically used acquisitions to fuel expansion into new regions and production growth.

Read more on KGC →

About Tenet Healthcare Corporation

Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.

Read more on THC →